OncoVerity
Computational tools advance cancer therapies, transforming hope into reality for patients.
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Series A | |
Total Funding | 000k |
Related Content
Oncoverity leverages computational tools and bioinformatics to advance cancer therapies, focusing on transforming hope into reality for patients. The company operates in the healthcare sector, specifically targeting oncology and hematology markets. By integrating academic and industry expertise, Oncoverity identifies novel therapeutic targets using multi-omics data, aiming to deliver transformative solutions to patients. The business model revolves around research and development, collaborating with internal and external experts to drive breakthrough results. Oncoverity serves healthcare providers and patients, making money through the development and commercialization of cancer therapies. The company's approach is characterized by its commitment to challenging conventions and advancing assets with unrealized potential.
Keywords: computational tools, cancer therapies, bioinformatics, oncology, hematology, multi-omics, therapeutic targets, research, development, collaboration